Avantor Inc
(NYSE:AVTR)
$
21.06
0.02 (0.1%)
Market Cap: 14.33 Bil
Enterprise Value: 18.97 Bil
PE Ratio: 46.80
PB Ratio: 2.58
GF Score: 76/100 Avantor Inc at Goldman Sachs Global Healthcare Conference Transcript
Jun 14, 2022 / 03:00PM GMT
Release Date Price:
$29.72
(+1.26%)
Matthew Carlisle Sykes
Goldman Sachs Group, Inc., Research Division - Research Analyst
All right. I think we're ready to go. Welcome, everyone. I'm Matt Sykes, the life sciences tools and diagnostics analyst at Goldman Sachs. I have the pleasure of welcoming Avantor here today. We have Michael Stubblefield, the Chief Executive Officer. Move on toward Michael, thank you very much for joining us today.
Michael Stubblefield
Avantor, Inc. - President, CEO & Director
Yes. Thanks, Matt. It's great to be here in person.
Questions & Answers
Matthew Carlisle Sykes
Goldman Sachs Group, Inc., Research Division - Research Analyst
Maybe if you could help us set the stage initially and spend a few minutes Avantor, and including a brief review in the most recent quarter.
Michael Stubblefield
Avantor, Inc. - President, CEO & Director
Yes, that's a great place to start and certainly appreciate the opportunity to talk about our business. Avantor is a really unique
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot